Experience with daily self-administered subcutaneous erythropoietin.
Granolleras
C
C
Department of Nephrology, University Hospital, Nîmes, France.
Branger
B
B
Beau
M C
MC
Deschodt
G
G
Alsabadani
B
B
Shaldon
S
S
D000328:Adult; D000368:Aged; D000740:Anemia / Q000097:blood / Q000150:complications / Q000188:drug therapy*; D002986:Clinical Trials as Topic; D004334:Drug Administration Schedule; D004921:Erythropoietin / Q000008:administration & dosage*; D005260:Female; D006400:Hematocrit; D006454:Hemoglobins / Q000378:metabolism; D006801:Humans; D007279:Injections, Subcutaneous; D007676:Kidney Failure, Chronic / Q000150:complications; D008297:Male; D008875:Middle Aged; D012646:Self Administration
D006454:Hemoglobins; D004921:Erythropoietin